Interphase fluorescence in situ hybridization improves the detection of malignant cells in effusions from breast cancer patients
1997

Using FISH to Detect Cancer Cells in Breast Effusions

Sample size: 57 publication Evidence: high

Author Information

Author(s): N Zojerl, M FiegIl, J Angerlerl, L Mullauer, A Gsurl, S Rokal, M Pecherstorfer, H Huber, J Drach

Primary Institution: University of Vienna

Hypothesis

Can fluorescence in situ hybridization (FISH) improve the detection of malignant cells in effusions from breast cancer patients?

Conclusion

FISH is a valuable tool for diagnosing malignancy in breast cancer effusions, significantly improving detection rates compared to routine cytology.

Supporting Evidence

  • Routine cytology identified malignancy in 60% of effusions.
  • FISH detected aneuploid cell populations in 94% of cytologically positive effusions.
  • FISH revealed true aneuploidy in 48% of cytologically negative effusions.

Takeaway

Scientists used a special test called FISH to find cancer cells in fluid from breast cancer patients, and it worked much better than the usual tests.

Methodology

The study evaluated 57 effusion samples from breast cancer patients using routine cytology and FISH with specific chromosome probes.

Limitations

The study may not account for all types of non-malignant effusions and relies on specific cut-off levels for aneuploidy.

Participant Demographics

41 breast cancer patients aged 41 to 85 years, median age 58.

Statistical Information

P-Value

p<0.01

Statistical Significance

p<0.05

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication